| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |